ag 127 and Leukemia, Pre-B-Cell

ag 127 has been researched along with Leukemia, Pre-B-Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Goi, K; Inukai, T; Kagami, K; Kojika, S; Lijima, K; Miyamoto, N; Nakamura, M; Nakazawa, S; Sugita, K; Tezuka, T	1

Other Studies

1 other study(ies) available for ag 127 and Leukemia, Pre-B-Cell

Article	Year
The JAK2 inhibitor AG490 predominantly abrogates the growth of human B-precursor leukemic cells with 11q23 translocation or Philadelphia chromosome. Leukemia, 2001, Volume: 15, Issue:11 Topics: Antineoplastic Agents; Cell Division; Chromosomes, Human, Pair 11; DNA, Neoplasm; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fusion Proteins, bcr-abl; Humans; Janus Kinase 2; Leukemia, Lymphoid; Philadelphia Chromosome; Phosphorylation; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Translocation, Genetic; Tumor Cells, Cultured; Tumor Stem Cell Assay; Tyrphostins	2001

Article

Year

The JAK2 inhibitor AG490 predominantly abrogates the growth of human B-precursor leukemic cells with 11q23 translocation or Philadelphia chromosome.

Leukemia, 2001, Volume: 15, Issue:11

Topics: Antineoplastic Agents; Cell Division; Chromosomes, Human, Pair 11; DNA, Neoplasm; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fusion Proteins, bcr-abl; Humans; Janus Kinase 2; Leukemia, Lymphoid; Philadelphia Chromosome; Phosphorylation; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Translocation, Genetic; Tumor Cells, Cultured; Tumor Stem Cell Assay; Tyrphostins

2001